In addition, using Kaplan–Meier survival analysis and TCGA datasets, we showed that patients with cervical cancer and high CD36 expression levels had an unfavorable prognosis relative to those with low or medium CD36 expression (Fig. 1e) (P = 0.02). This evidence concerns the gene CD36 and cervical carcinoma.